NEW
Stock Screener with Intrinsic Value
Summit Therapeutics Inc. (SMMT)
Last Price$19.04.6%
Market Cap$13.8B
386.0%
Industry median - 65.3%
5Y Historical average - 54.7%
83,760.9%
Industry median - (867.7%)
5Y Historical average - (25,045.8%)
48,028.4%
Industry median - (726.1%)
5Y Historical average - (1,200.3%)
57.4%
Industry median - 83.4%
5Y Historical average - 67.0%
SMMT Profitability Rating
Crunching data... Almost there!
SMMT Profitability Metrics
Crunching data... Almost there!
Competing with SMMT Profitability
Overview
Ratings
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
FAQ
What is the Summit Therapeutics Inc. (SMMT) gross profit margin?
The Summit Therapeutics Inc. (SMMT) gross profit margin is 386.0%, compared to the industry median of 65.3% and the 5-year historical average of 54.7%.
What is the Summit Therapeutics Inc. (SMMT) operating income margin?
The Summit Therapeutics Inc. (SMMT) operating income margin is 83,760.9%, compared to the industry median of (867.7%)) and the 5-year historical average of (25,045.8%).
What is the Summit Therapeutics Inc. (SMMT) Free Cash Flow (FCF) margin?
The Summit Therapeutics Inc. (SMMT) Free Cash Flow margin is 48,028.4%, compared to the industry median of (726.1%) and the 5-year historical average of (1,200.3%).
What is the Summit Therapeutics Inc. (SMMT) earnings quality?
The Summit Therapeutics Inc. (SMMT) earnings quality is 57.4%, compared to the industry median of 83.4% and the 5-year historical average of 67.0%.